STAT — Reporting from the frontiers of health and medicine
- Biotech STAT Plus: No more ‘playing God’: How the longevity field is trying to recast its work as serious science
- Health Tech STAT Plus: These blood-clot catching devices have been controversial for years. Why are doctors still relying on them?
- Health STAT Plus: They were the 10% left out of life-changing treatments. Now these cystic fibrosis patients may finally get help
- Pharmalot STAT Plus: Leading ALS advocacy group roiled by infighting over money and priorities
- First Opinion I was laid off from a public health job. Trust me, tech layoffs are different
- First Opinion The FDA is the right agency to regulate CBD products, but it needs help
- The Readout LOUD Listen: Pharma blockbusters, pandemic policy, & legal chicanery
- Biotech STAT Plus: No more ‘playing God’: How the longevity field is trying to recast its work as serious science
- Health Tech STAT Plus: These blood-clot catching devices have been controversial for years. Why are doctors still relying on them?
- Health STAT Plus: They were the 10% left out of life-changing treatments. Now these cystic fibrosis patients may finally get help
- Pharmalot STAT Plus: Leading ALS advocacy group roiled by infighting over money and priorities
- First Opinion I was laid off from a public health job. Trust me, tech layoffs are different
- First Opinion The FDA is the right agency to regulate CBD products, but it needs help
- The Readout LOUD Listen: Pharma blockbusters, pandemic policy, & legal chicanery
advertisement

STAT Plus: ‘Out of control’: Dozens of telehealth startups sent sensitive health information to big tech companies
By Katie Palmer — STAT and Todd Feathers and Simon Fondrie-Teitler — The Markup
- First Opinion I was laid off from a public health job. Trust me, tech layoffs are different
- Politics STAT Plus: The unexpected alliance lobbying for Medicare to pay for new obesity drugs
- Health Tech STAT Plus: ChatGPT in health care: 5 burning questions about the buzzy new tool
-
- Hospitals STAT Plus: Hospitals gear up to expand market power, raise prices in 2023
- Politics STAT Plus: Medicare may test policy of paying less for accelerated approval drugs
- Health In gold-standard trial, invitation to colonoscopy reduced cancer incidence but not death
- First Opinion Disruptive science is leaping forward, not limping along
- First Opinion Promises — and pitfalls — of ChatGPT-assisted medicine
- Health Flawed herpes testing leads to many false positives — and needless suffering
Reporter Spotlight

Ambar Castillo is a 2022-2023 Sharon Begley Science Reporting Fellow at STAT.

Nicholas Florko reports on the commercial determinants of health.

Brittany Trang is a 2022-2023 Sharon Begley Science Reporting Fellow at STAT.